Match tier Confirmed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-08

Alexei G. Basnakian

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI High Impact

Professor

Also affiliated: Tufts University (1997); Boston Biomedical Research Institute (1989); United States Food and Drug Administration (1994–1996); University of Debrecen (2005); University of Arkansas Medical Center (2002–2024); Ege University (2007); Central Arkansas Veterans Healthcare System (2001–2025); Jean Mayer Human Nutrition Research Center on Aging (1997); Institute of Biomedical Chemistry (1991); John L. McClellan Memorial Veterans Hospital (2006–2024); Ege Üniversitesi Tıp Fakültesi Hastanesi (2007)

37 h-index 144 pubs 4,508 cited

  • Animals
  • Humans
  • Apoptosis
  • Mice
  • Rats
  • DNA Fragmentation
  • Endodeoxyribonucleases
  • Male
  • Cell Line
  • Cells, Cultured
  • DNA Damage
  • Lipoproteins, LDL
  • DNA
  • Mice, Knockout
  • Deoxyribonuclease I

Biography and Research Information

OverviewAI-generated summary

Alexei G. Basnakian's research program investigates mechanisms of cellular injury and death, with a particular focus on kidney disease and cancer. His work has explored the role of DNA damage, apoptosis, and metabolic imbalances in the development of these conditions. Basnakian has studied the effects of nutrient deficiencies, such as folate deficiency, on DNA integrity and mutagenesis in cell culture models and animal studies. He has also investigated the contribution of modified lipoproteins, like carbamylated low-density lipoprotein, to the pathogenesis of atherosclerosis, especially in the context of chronic kidney disease.

His laboratory employs various techniques, including the TUNEL assay for evaluating kidney injury. Basnakian has received federal funding from the NIH for his research, including a BLRD Research Career Scientist Award, and has served as PI on grants examining nuclease mechanisms in acute kidney injury. He has a publication record of 142 papers with over 4,100 citations and an h-index of 36, reflecting his significant contributions to the field. Basnakian actively collaborates with researchers at the University of Arkansas for Medical Sciences, including Martin J. Cannon, Steven R. Post, Camila Simões, and Mulu Z. Tesfay.

Metrics

  • h-index: 37
  • Publications: 144
  • Citations: 4,508

Positions

  • Professor publications 1996–2026
    University of Arkansas for Medical Sciences Department of Pharmacology and Toxicology Institutional directory

Selected Publications

  • Dual Targeting of EZH2 and LSD1 Suppresses Hepatocellular Carcinoma via Disruption of Sonic Hedgehog Signaling (2026)
    International Journal of Molecular Sciences 1 citation DOI OpenAlex
  • Abstract 4378: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models (2026)
    Cancer Research DOI OpenAlex
  • An enhancement of extrachromosomal circular DNA enrichment and amplification to address the extremely low overlap between replicates (2026)
    Journal of Biological Chemistry DOI OpenAlex
  • Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection (2026)
    ChemRxiv 1 citation DOI OpenAlex
  • Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response (2026)
    Journal for ImmunoTherapy of Cancer DOI OpenAlex
  • Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma models (2025)
    Frontiers in Immunology 1 citation DOI OpenAlex
  • Abstract B022: Reprogramming Apoptotic Resistance in PDAC Through Synthetic Oncolytic Immunotherapy (2025)
    Cancer Research DOI OpenAlex
  • An Enhancement of Extrachromosomal Circular DNA Enrichment and Amplification to Address the Extremely Low Overlap Between Replicates (2025)
    bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex
  • Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models (2025)
    Cancer Research DOI OpenAlex
  • Abstract 947: Engineering a synthetic oncolytic virus to overcome apoptotic resistance and induce immunogenic cell death in pancreatic ductal adenocarcinoma (2025)
    Cancer Research DOI OpenAlex
  • Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors (2025)
    RSC Medicinal Chemistry DOI OpenAlex
  • The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury (2025)
    American Journal of Physiology-Renal Physiology 3 citations DOI OpenAlex
  • Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors (2024)
    RSC Medicinal Chemistry 1 citation DOI OpenAlex
  • Generation of BT-Amide, a Bone-Targeted Pyk2 Inhibitor, Effective via Oral Administration, for the Prevention of Glucocorticoid-Induced Bone Loss (2024)
    Journal of Medicinal Chemistry 5 citations DOI OpenAlex
  • Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer (2024)
    Biomedicines 6 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 2

VA Contact PI Oct 2022 - Sep 2027

BLRD Research Career Scientist Award Application

Administered by Central Arkansas Veterans Healthcare System IK6
VA Contact PI Oct 2014 - Aug 2028

Nuclease mechanisms in acute kidney injury

Administered by Central Arkansas Veterans Healthcare System I01

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

  • The role of endonuclease G in nuclear apoptosis of atrophying skeletal muscle NIH/Nat. Inst. of Arthritis & Musculoskeletal & Skin Diseases via University of Kentucky Research Foundation
  • Endonuclease-targeted radioprotection NIH/Nat. Inst. of Allergy & Infectious Diseases via Duke University
  • Endonuclease dificiency in breast cancer progression NIH
  • Novel DNA damage-based technology for evaluation of graphene toxicity in vitro and in vivo U.S. Food and Drug Administration via Arkansas Research Alliance
  • A nanotherapeutic approach to combat staphylococcal biofilm-associated infection NIH
  • CRIC Ancillary Study: Carbamylated low-density lipoprotein and cardiovascular eve NIH
  • LDL isoforms in kidney-related atherosclerosisv NIH
  • Using Advanced Functional Nanomaterials to Fight Cancer. U.S. Army Medical Research & Materiel Command via University of Arkansas at Little Rock

Collaboration Network

312 Collaborators 69 Institutions 17 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics